Inhibition of Proliferation, Migration and Proteolysis Contribute to Corticosterone-Mediated Inhibition of Angiogenesis

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Shikatani, Eric A ^a,b   Trifonova, Anastassia ^a,b   Mandel, Erin R ^a   Liu, Sammy T K ^a   Roudier, Emilie ^a   Krylova, Anna ^a   Szigiato, Andrei ^a   Beaudry, Jacqueline ^a,b   Riddell, Michael C ^a,b   Haas, Tara L ^a,b  

^a YORK UNIVERSITY   (Canada)

^b YORK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; GELATINASE A; PLACEBO; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR SP1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASSAY; CAPILLARY; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; EX VIVO STUDY; MICROVASCULATURE; MONOLAYER CULTURE; NONHUMAN; PATHOPHYSIOLOGY; PROMOTER REGION; PROTEIN DEGRADATION; RAT; RODENT; SKELETAL MUSCLE; TIBIALIS ANTERIOR MUSCLE;

ANIMALS; BIOTINYLATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CORTICOSTERONE; HUMANS; MATRIX METALLOPROTEINASE 2; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

RATTUS; RODENTIA;

EID: 84867021930     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046625     Document Type: Article

References (61)

1. Ausprunk DH, Folkman J, (1977) Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 14: 53-65.
2. Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, et al. (2003) Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 9: 936-943.
3. Hudlicka O, Brown M, Egginton S, (1992) Angiogenesis in skeletal and cardiac muscle. Physiol Rev 72: 369-417.
4. Folkman J, Langer R, Linhardt RJ, Haudenschild C, Taylor S, (1983) Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science 221: 719-725.
5. Folkman J, Ingber DE, (1987) Angiostatic steroids. Method of discovery and mechanism of action. Ann Surg 206: 374-383.
6. Small GR, Hadoke PW, Sharif I, Dover AR, Armour D, et al. (2005) Preventing local regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 enhances angiogenesis. Proc Natl Acad Sci USA 102: 12165-12170.
7. Weinstein RS, Wan C, Liu Q, Wang Y, Almeida M, et al. (2010) Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell 9: 147-161.
8. Logie JJ, Ali S, Marshall KM, Heck MM, Walker BR, et al. (2010) Glucocorticoid-mediated inhibition of angiogenic changes in human endothelial cells is not caused by reductions in cell proliferation or migration. PLoS One 5: e14476.
9. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, et al. (1989) Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84: 1470-1478.
10. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, et al. (2003) VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161: 1163-1177.
11. Forster C, Kahles T, Kietz S, Drenckhahn D, (2007) Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND. J Physiol 580: 937-949.
12. Mayanagi T, Morita T, Hayashi K, Fukumoto K, Sobue K, (2008) Glucocorticoid receptor-mediated expression of caldesmon regulates cell migration via the reorganization of the actin cytoskeleton. J Biol Chem 283: 31183-31196.
13. Li S, Chen BP, Azuma N, Hu YL, Wu SZ, et al. (1999) Distinct roles for the small GTPases Cdc42 and Rho in endothelial responses to shear stress. J Clin Invest 103: 1141-1150.
14. Nobes CD, Hall A, (1995) Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81: 53-62.
15. Raftopoulou M, Hall A, (2004) Cell migration: Rho GTPases lead the way. Dev Biol 265: 23-32.
16. Nagase H, Woessner JF Jr, (1999) Matrix metalloproteinases. J Biol Chem 274: 21491-21494.
17. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM, (2000) Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18: 1135-1149.
18. Rundhaug JE, (2005) Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9: 267-285.
19. Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, et al. (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85: 683-693.
20. Fang J, Shing Y, Wiederschain D, Yan L, Butterfield C, et al. (2000) Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci USA 97: 3884-3889.
21. Hernandez-Barrantes S, Toth M, Bernardo MM, Yurkova M, Gervasi DC, et al. (2000) Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J Biol Chem 275: 12080-12089.
22. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, et al. (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270: 5331-5338.
23. Yang EV, Bane CM, MacCallum RC, Kiecolt-Glaser JK, Malarkey WB, et al. (2002) Stress-related modulation of matrix metalloproteinase expression. J Neuroimmunol 133: 144-150.
24. Aljada A, Ghanim H, Mohanty P, Hofmeyer D, Tripathy D, et al. (2001) Hydrocortisone suppresses intranuclear activator-protein-1 (AP-1) binding activity in mononuclear cells and plasma matrix metalloproteinase 2 and 9 (MMP-2 and MMP-9). J Clin Endocrinol Metab 86: 5988-5991.
25. Aho S, Rouda S, Kennedy SH, Qin H, Tan EM, (1997) Regulation of human interstitial collagenase (matrix metalloproteinase-1) promoter activity by fibroblast growth factor. Eur J Biochem 247: 503-510.
26. Stojadinovic O, Lee B, Vouthounis C, Vukelic S, Pastar I, et al. (2007) Novel genomic effects of glucocorticoids in epidermal keratinocytes: inhibition of apoptosis, interferon-gamma pathway, and wound healing along with promotion of terminal differentiation. J Biol Chem 282: 4021-4034.
27. Campbell JE, Peckett AJ, D'Souza AM, Hawke TJ, Riddell MC, (2011) Adipogenic and lipolytic effects of chronic glucocorticoid exposure. Am J Physiol Cell Physiol 300: C198-C209.
28. Haas TL, Davis SJ, Madri JA, (1998) Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J Biol Chem 273: 3604-3610.
29. Han X, Boyd PJ, Colgan S, Madri JA, Haas TL, (2003) Transcriptional up-regulation of endothelial cell matrix metalloproteinase-2 in response to extracellular cues involves GATA-2. J Biol Chem 278: 47785-47791.
30. Korff T, Augustin HG, (1998) Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J Cell Biol 143: 1341-1352.
31. Haas TL, Stitelman D, Davis SJ, Apte SS, Madri JA, (1999) Egr-1 mediates extracellular matrix-driven transcription of membrane type 1 matrix metalloproteinase in endothelium. J Biol Chem 274: 22679-22685.
32. Oh J, Takahashi R, Adachi E, Kondo S, Kuratomi S, et al. (2004) Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice. Oncogene 23: 5041-5048.
33. Zhang X, Tang N, Hadden TJ, Rishi AK, (2011) Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta 1813: 1978-1986.
34. Ispanovic E, Haas TL, (2006) JNK and PI3K differentially regulate MMP-2 and MT1-MMP mRNA and protein in response to actin cytoskeleton reorganization in endothelial cells. Am J Physiol Cell Physiol 291: C579-C588.
35. Qin H, Sun Y, Benveniste EN, (1999) The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem 274: 29130-29137.
36. Boyd PJ, Doyle J, Gee E, Pallan S, Haas TL, (2005) MAPK signaling regulates endothelial cell assembly into networks and expression of MT1-MMP and MMP-2. Am J Physiol Cell Physiol 288: C659-C668.
37. Pages G, Pouyssegur J, (2005) Transcriptional regulation of the Vascular Endothelial Growth Factor gene-a concert of activating factors. Cardiovasc Res 65: 564-573.
38. Uchida C, Gee E, Ispanovic E, Haas TL, (2008) JNK as a positive regulator of angiogenic potential in endothelial cells. Cell BiolInt 32: 769-776.
39. Haller J, Mikics E, Makara GB, (2008) The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings. Front Neuroendocrinol 29: 273-291.
40. Blecharz KG, Drenckhahn D, Forster CY, (2008) Glucocorticoids increase VE-cadherin expression and cause cytoskeletal rearrangements in murine brain endothelial cEND cells. JCerebBlood Flow Metab 28: 1139-1149.
41. Oberleithner H, Riethmuller C, Ludwig T, Shahin V, Stock C, et al. (2006) Differential action of steroid hormones on human endothelium. J Cell Sci 119: 1926-1932.
42. Cantrill HL, Waltman SR, Palmberg PF, Zink HA, Becker B, (1975) In vitro determination of relative corticosteroid potency. J Clin Endocrinol Metab 40: 1073-1077.
43. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L, (2006) VEGF receptor signalling- in control of vascular function. Nat Rev Mol Cell Biol 7: 359-371.
44. Kim EK, Choi EJ, (2010) Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta 1802: 396-405.
45. Manning BD, Cantley LC, (2007) AKT/PKB signaling: navigating downstream. Cell 129: 1261-1274.
46. Rubenstein NM, Guan Y, Woo PL, Firestone GL, (2003) Glucocorticoid down-regulation of RhoA is required for the steroid-induced organization of the junctional complex and tight junction formation in rat mammary epithelial tumor cells. JBiolChem 278: 10353-10360.
47. Aepfelbacher M, Essler M, Huber E, Sugai M, Weber PC, (1997) Bacterial toxins block endothelial wound repair. Evidence that Rho GTPases control cytoskeletal rearrangements in migrating endothelial cells. Arterioscler Thromb Vasc Biol 17: 1623-1629.
48. Zeng H, Zhao D, Mukhopadhyay D, (2002) KDR stimulates endothelial cell migration through heterotrimeric G protein Gq/11-mediated activation of a small GTPase RhoA. J Biol Chem 277: 46791-46798.
49. van Nieuw Amerongen GP, Koolwijk P, Versteilen A, van Hinsbergh VW, (2003) Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro. Arterioscler Thromb Vasc Biol 23: 211-217.
50. Bryan BA, Dennstedt E, Mitchell DC, Walshe TE, Noma K, et al. (2010) RhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis. FASEB J 24: 3186-3195.
51. Haas TL, Milkiewicz M, Davis SJ, Zhou AL, Egginton S, et al. (2000) Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle. Am J Physiol Heart Circ Physiol 279: H1540-1547.
52. Harkness KA, Adamson P, Sussman JD, vies-Jones GA, Greenwood J, et al. (2000) Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. Brain 123 (Pt 4): 698-709.
53. Park MT, Cha HJ, Jeong JW, Kim SI, Chung HY, et al. (1999) Glucocorticoid receptor-induced down-regulation of MMP-9 by ginseng components, PD and PT contributes to inhibition of the invasive capacity of HT1080 human fibrosarcoma cells. Mol Cells 9: 476-483.
54. Russell RE, Culpitt SV, DeMatos C, Donnelly L, Smith M, et al. (2002) Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 26: 602-609.
55. Xu J, Kim GM, Ahmed SH, Yan P, Xu XM, et al. (2001) Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury. J Neurosci 21: 92-97.
56. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, et al. (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65.
57. Song IH, Buttgereit F, (2006) Non-genomic glucocorticoid effects to provide the basis for new drug developments. Mol Cell Endocrinol 246: 142-146.
58. Harendza S, Pollock AS, Mertens PR, Lovett DH, (1995) Tissue-specific enhancer-promoter interactions regulate high level constitutive expression of matrix metalloproteinase 2 by glomerular mesangial cells. J Biol Chem 270: 18786-18796.
59. Goldman S, Lovett DH, Shalev E, (2009) Mechanisms of matrix metalloproteinase-2 (mmp-2) transcriptional repression by progesterone in jar choriocarcinoma cells. Reprod Biol Endocrinol 7: 41.
60. Urbich C, Knau A, Fichtlscherer S, Walter DH, Bruhl T, et al. (2005) FOXO-dependent expression of the proapoptotic protein Bim: pivotal role for apoptosis signaling in endothelial progenitor cells. FASEB J 19: 974-976.
61. Potente M, Urbich C, Sasaki K, Hofmann WK, Heeschen C, et al. (2005) Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest 115: 2382-2392.